This is not the most recent version of the article. View current version (21 OCT 2015)

Intervention Review

You have free access to this content

Stiripentol for focal refractory epilepsy

  1. Francesco Brigo1,*,
  2. Monica Storti2

Editorial Group: Cochrane Epilepsy Group

Published Online: 31 JAN 2014

Assessed as up-to-date: 19 AUG 2013

DOI: 10.1002/14651858.CD009887.pub2


How to Cite

Brigo F, Storti M. Stiripentol for focal refractory epilepsy. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD009887. DOI: 10.1002/14651858.CD009887.pub2.

Author Information

  1. 1

    Franz Tappeiner Hospital, Department of Neurology, Merano, Italy

  2. 2

    Franz Tappeiner Hospital, Department of Medicine, Merano, Italy

*Francesco Brigo, Department of Neurology, Franz Tappeiner Hospital, Via Rossini, 5, Merano, 39012, Italy. dr.francescobrigo@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2014

SEARCH

This is not the most recent version of the article. View current version (21 OCT 2015)

[Figure 1]
Figure 1. Study flow diagram.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Add-on stiripentol versus placebo, Outcome 1 ≥ 50% seizure reduction.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Add-on stiripentol versus placebo, Outcome 2 Seizure freedom.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Add-on stiripentol versus placebo, Outcome 3 At least one adverse effect.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Add-on stiripentol versus placebo, Outcome 4 Neurologic adverse effects.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Add-on stiripentol versus placebo, Outcome 5 Gastrointestinal adverse effects.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Add-on stiripentol versus placebo, Outcome 6 Drop-outs.